Single Arm Romiplostim to Prevent CIT
Single Arm Evaluation of Romiplostim to Prevent Chemotherapy Induced Thrombocytopenia in Patients With Ewing Sarcoma
Sponsor: Children's Hospital Medical Center, Cincinnati
A EARLY_PHASE1 clinical study on Chemotherapy Induced Thrombocytopenia and Ewings Sarcoma, this trial is actively recruiting participants. The trial is conducted by Children's Hospital Medical Center, Cincinnati and has accumulated 2 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
2 versions recorded-
Jan 2026 — Present [monthly]
Recruiting EARLY_PHASE1
-
Aug 2025 — Jan 2026 [monthly]
Recruiting EARLY_PHASE1
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .